Psychiatric Association Wants FDA to Expand Electroshock Used on Children and Elderly

The Food and Drug Administration (FDA) has allowed the electroshock therapy (ECT) device to remain on the market without requiring clinical studies proving safety and efficacy, and is considering the American Psychiatric Association’s written proposal to expand ECT’s use on the general public, including on children. According to the FDA’s mission statement, the FDA “is responsible for protecting the public health by ensuring the safety” and “efficacy” of medical products, including “medical devices” (the ECT device included). Due to the documented risks attributed to ECT, we are calling on the FDA to prohibit its use.